Many studies have tried to demonstrate the beneficial effect of adding insulin sensitiser agents to peginterferon and ribavirin in order to enhance viral clearance in genotype 1 chronic hepatitis C with insulin resistance. Here, INS is linked to chronic hepatitis C virus infection.